申请人:CHEMOCENTRYX INC
公开号:WO2006038989A1
公开(公告)日:2006-04-13
The invention relates to compounds (I) wherein the variables are as defined in the specification. They inhibit the binding of the SDF-1 chemokine or I-TAC to the chemokine receptor CCXCKR2 and are useful in preventing tumor cell proliferation, tumor formation, and metastasis.